CVS Health CorporationCVSNYSE
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank100
5Y CAGR+86.6%
Year-over-Year Change
Year-over-year free cash flow growth rate
5Y CAGR
+86.6%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
22.7x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 2559.18% |
| Q3 2025 | -92.40% |
| Q2 2025 | -66.17% |
| Q1 2025 | 249.18% |
| Q4 2024 | 177.17% |
| Q3 2024 | -157.73% |
| Q2 2024 | -41.62% |
| Q1 2024 | 218.35% |
| Q4 2023 | -263.38% |
| Q3 2023 | -59.17% |
| Q2 2023 | -17.62% |
| Q1 2023 | 344.47% |
| Q4 2022 | -130.90% |
| Q3 2022 | 69.67% |
| Q2 2022 | 100.44% |
| Q1 2022 | -26.29% |
| Q4 2021 | -30.63% |
| Q3 2021 | -8.36% |
| Q2 2021 | 159.86% |
| Q1 2021 | -27.72% |
| Q4 2020 | 112.99% |
| Q3 2020 | -79.91% |
| Q2 2020 | 160.28% |
| Q1 2020 | 24.00% |
| Q4 2019 | -11.17% |
| Q3 2019 | -51.16% |
| Q2 2019 | 286.77% |
| Q1 2019 | -34.95% |
| Q4 2018 | 240.04% |
| Q3 2018 | -77.76% |
| Q2 2018 | 33.69% |
| Q1 2018 | 391.74% |
| Q4 2017 | -130.76% |
| Q3 2017 | 33.10% |
| Q2 2017 | -49.02% |
| Q1 2017 | 104.52% |
| Q4 2016 | -56.14% |
| Q3 2016 | 200.00% |
| Q2 2016 | -37.91% |
| Q1 2016 | -31.66% |